Cargando…

Using MRI to predict future adverse cardiac remodelling in a male mouse model of myocardial infarction

BACKGROUND: Mice are frequently used in research to examine outcomes of myocardial infarction (MI) and to investigate therapeutic interventions at an early pre-clinical stage. The MI model is generated by surgically occluding a major coronary artery, but natural variation in murine coronary anatomy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Redgrave, Rachael E., Tual-Chalot, Simon, Davison, Benjamin J., Greally, Elizabeth, Santibanez-Koref, Mauro, Schneider, Jurgen E., Blamire, Andrew M., Arthur, Helen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111480/ https://www.ncbi.nlm.nih.gov/pubmed/27882341 http://dx.doi.org/10.1016/j.ijcha.2016.03.005

Ejemplares similares

Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction
por: Redgrave, Rachael, et al.
Publicado: (2023)

Pharmacological clearance of senescent cells improves survival and recovery in aged mice following acute myocardial infarction
por: Walaszczyk, Anna, et al.
Publicado: (2019)

Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction
por: Redgrave, Rachael E., et al.
Publicado: (2023)

Author Correction: Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction
por: Redgrave, Rachael E., et al.
Publicado: (2023)

Cardiosphere-Derived Cells Require Endoglin for Paracrine-Mediated Angiogenesis
por: Redgrave, Rachael E., et al.
Publicado: (2017)

Endothelial Depletion of Acvrl1 in Mice Leads to Arteriovenous Malformations Associated with Reduced Endoglin Expression
por: Tual-Chalot, Simon, et al.
Publicado: (2014)

Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling
por: Tual-Chalot, Simon, et al.
Publicado: (2020)

Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges
por: Tual-Chalot, Simon, et al.
Publicado: (2015)

Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers
por: Berezin, Alexander E., et al.
Publicado: (2020)

Impaired Autophagy Contributes to Adverse Cardiac Remodeling in Acute Myocardial Infarction
por: Wu, Xiaoqian, et al.
Publicado: (2014)

Eosinophil Deficiency Promotes Aberrant Repair and Adverse Remodeling Following Acute Myocardial Infarction
por: Toor, Iqbal S., et al.
Publicado: (2020)

Association of increased oncostatin M with adverse left ventricular remodeling in patients with myocardial infarction
por: Gusakova, Anna M., et al.
Publicado: (2022)

Apelin Is a Prototype of Novel Drugs for the Treatment of Acute Myocardial Infarction and Adverse Myocardial Remodeling
por: Popov, Sergey V., et al.
Publicado: (2023)

Intravascular Stem Cell Bioreactor for Prevention of Adverse Remodeling After Myocardial Infarction
por: Johnston, Peter V., et al.
Publicado: (2019)

The Role of Ferroptosis in Adverse Left Ventricular Remodeling Following Acute Myocardial Infarction
por: Komai, Kyoko, et al.
Publicado: (2022)

Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarction
por: Al Ali, Lawien, et al.
Publicado: (2023)

Runx1 Deficiency Protects Against Adverse Cardiac Remodeling After Myocardial Infarction
por: McCarroll, Charlotte S., et al.
Publicado: (2018)

Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction
por: Dick, Sarah A, et al.
Publicado: (2018)

Development of cardiac remodeling in patients with acute myocardial infarction studied by cardiac MRI (CMR)
por: Sinn, Martin R, et al.
Publicado: (2015)

Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction
por: Louwe, Mieke C., et al.
Publicado: (2020)

Lymphangiogenesis in myocardial remodelling after infarction
por: Ishikawa, Y, et al.
Publicado: (2007)

Fimasartan for Remodeling after Myocardial Infarction
por: Lim, Byung-Kwan, et al.
Publicado: (2019)

Fibroblast-specific deletion of IL-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction
por: Bageghni, Sumia A., et al.
Publicado: (2019)

Long-term administration of recombinant canstatin prevents adverse cardiac remodeling after myocardial infarction
por: Sugiyama, Akira, et al.
Publicado: (2020)

Serum Soluble ST2 and Adverse Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction
por: Kercheva, Maria, et al.
Publicado: (2019)

Left ventricular remodeling following myocardial infarction revealed with a quantitative diffusion MRI tractography framework
por: Mekkaoui, Choukri, et al.
Publicado: (2012)

Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia
por: Gallardo-Vara, Eunate, et al.
Publicado: (2018)

MRI evaluation of the role of No-Reflow in left ventricular remodeling after Acute Myocardial Infarction (AMI)
por: Liguori, Carlo, et al.
Publicado: (2009)

PPARα Is Essential for Microparticle-Induced Differentiation of Mouse Bone Marrow-Derived Endothelial Progenitor Cells and Angiogenesis
por: Benameur, Tarek, et al.
Publicado: (2010)

ECG Marker of Adverse Electrical Remodeling Post-Myocardial Infarction Predicts Outcomes in MADIT II Study
por: Tereshchenko, Larisa G., et al.
Publicado: (2012)

A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction
por: Mullany, Lisa K., et al.
Publicado: (2020)

A Steroid Receptor Coactivator Stimulator MCB-613 Attenuates Adverse Remodeling After Myocardial Infarction
por: Mullany, Lisa K, et al.
Publicado: (2021)

Renal Denervation Attenuates Adverse Remodeling and Intramyocardial Inflammation in Acute Myocardial Infarction With Ischemia–Reperfusion Injury
por: Wang, Kun, et al.
Publicado: (2022)

Reproducing extracellular matrix adverse remodelling of non-ST myocardial infarction in a large animal model
por: Contessotto, Paolo, et al.
Publicado: (2023)

Hemorrhage contributes to chronic adverse remodeling in acute myocardial infarction: Insights from a novel preclinical model
por: Ghugre, Nilesh R, et al.
Publicado: (2015)

Rev-erb agonist improves adverse cardiac remodeling and survival in myocardial infarction through an anti-inflammatory mechanism
por: Stujanna, Endin Nokik, et al.
Publicado: (2017)

Orientin Reduces Myocardial Infarction Size via eNOS/NO Signaling and Thus Mitigates Adverse Cardiac Remodeling
por: Li, Fangfang, et al.
Publicado: (2017)

Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction
por: McLaughlin, Sarah, et al.
Publicado: (2019)

Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling
por: Schumacher, David, et al.
Publicado: (2021)

High fiber diet attenuate the inflammation and adverse remodeling of myocardial infarction via modulation of gut microbiota and metabolites
por: Zhao, Jinxuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fsvjpv806nq89hbfkuuda11c03